One theory suggests that Her-2 overexpression endows tumor cells with increased metastatic aggressiveness to sites such as the lungs and may similarly augment metastatic propensity to the CNS.53,54 The development of brain metastastic models for breast cancer can permit direct testing of this hypothesis through transfection experiments.